|Bid||8.57 x 2200|
|Ask||11.89 x 1000|
|Day's Range||11.24 - 11.86|
|52 Week Range||6.71 - 14.68|
|Beta (5Y Monthly)||1.26|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 11, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.00|
Champions Oncology, Inc. (CSBR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Champions Oncology, Inc. (CSBR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
The big shareholder groups in Champions Oncology, Inc. ( NASDAQ:CSBR ) have power over the company. Large companies...